News Latest News All News Media March 22,2019 News Our President & CEO Kazu Kuramori was at the Innate Killer Summit 2019 – Title:GAIA-102 as an NK Cell-Based “Upward Compatible” Modality Over CAR-T-Cell Therapy – March 12,2019 News GAIA BioMedicine has released an experimental kit to produce highly activated NK-like cells for research use 1 2 3 GAIA BioMedicine News
Latest News All News Media March 22,2019 News Our President & CEO Kazu Kuramori was at the Innate Killer Summit 2019 – Title:GAIA-102 as an NK Cell-Based “Upward Compatible” Modality Over CAR-T-Cell Therapy – March 12,2019 News GAIA BioMedicine has released an experimental kit to produce highly activated NK-like cells for research use 1 2 3